DUDLEY ROBERT MICHAEL (Chief Executive Officer) purchased 119.1% of their position (98K shares) of TRANSCODE THERAPEUTICS, INC. on the open market
Open‑market purchase worth $50.0K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 10/2/2023ACC: 0001104659-23-105924
DirectorOfficer10% Owner· Chief Executive Officer
Since Jul 2021
+98K
Net shares
Net buyer
$50.0K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
98K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+98K
Price / share
$0.51
Trade value
$49.98K
% of position
119.1%
9/28/2023
82.26K→180.26K
Total
Net shares
+98K
Net value
$49.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/28/2023 | P · Purchase | +98K | $0.51 | $49.98K | 119.1% | 82.26K | 180.26K |
| Total | +98K | $49.98K | ||||||
Derivative Transactions0
No derivative transactions reported